JENNIFER ROGERS: Open Payments
NPI 1487120465 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,561 in 100 payments from 24 companies in 2025. Trend: 2023 $4,367 · 2024 $2,573 · 2025 $2,561
Food & beverage: $2,561
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 10 | $284 |
| Novo Nordisk Inc | 9 | $260 |
| CeQur Corporation | 1 | $247 |
| AstraZeneca Pharmaceuticals LP | 8 | $240 |
| Amgen Inc. | 11 | $170 |
| ABBVIE INC. | 4 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $143 |
| Lilly USA, LLC | 7 | $130 |
| Mannkind Corporation | 5 | $112 |
| BETA BIONICS, INC. | 4 | $110 |
Products named: Korlym, CeQur Simplicity, Ozempic, Kerendia, JARDIANCE, AFREZZA, FARXIGA, iLet Bionic Pancreas.
Industry payments across NC — which companies pay providers there.
